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SUMMARY 
Upon infection of pathogens, neutrophils are the first white blood cells activated to entrap and kill 
invading microorganisms through the processes of phagocytosis or degranulation. A newly 
discovered mechanism used by neutrophils to eliminate bacteria, viruses and fungi is the release of 
neutrophil extracellular traps (NETs), web-like structures composed of nucleic acids, histones and 
selected cytoplasmic proteins, like myeloperoxidase and neutrophil elastase. In addition to their 
main defensive function, NETs were reported to promote thrombotic events and metastatic 
dissemination of cancer cells, but the mechanisms underlying these processes have not been 
elucidated yet. In this PhD thesis project, we tested the role of α5β1, αvβ3 and αIIbβ3 integrins in 
the adhesion of different human cancer cell lines using cell-free isolated NETs as substrate. 
Neutrophil-like cells, obtained after differentiating HL-60 cell line with DMSO, were stimulated 
with calcium ionophore A23187 and used as a stable source of NETs. Two human leukemia cell 
lines, differentially expressing α5β1 and αvβ3 integrins, were subjected to adhesion assays in the 
presence or absence of DNAse 1, blocking antibodies against α5β1 or αvβ3, alone or in 
combination with DNAse 1, and Proteinase K. As expected DNAse 1 treatment strongly inhibited 
adhesion of both cell lines to NETs. An equivalent significant reduction of cell adhesion to NETs 
was obtained after treatment of cells with blocking antibodies against α5β1 or αvβ3 indicating that 
both integrins were able to mediate cell adhesion to NETs. Furthermore, the combination of DNAse 
1 and anti-integrin antibody treatment almost completely blocked cell adhesion. Western blot 
analysis and immunoprecipitation experiments showed a dose-dependent increase of fibronectin 
levels in samples from stimulated neutrophil-like cells and a direct or indirect interaction of 
fibronectin with histone H3. Co-immunolocalization studies with confocal microscopy showed that 
fibronectin and citrullinated histone H3 co-localize inside the web-structure of NETs. Then, we 
screened a panel of human cancer cell lines endogenously expressing different protein levels of 
α5β1, αvβ3 and αIIbβ3 integrins in the adhesion to NETs: the concomitant expression of α5β1, 
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αvβ3 and αIIbβ3 integrins was associated to an enhanced adhesion to NETs and the addition of an 
excess of cyclic RGD peptide inhibited cell adhesion at a different extent in each cell line. 
Interestingly, the maximal reduction of integrin-dependent adhesion to NETs was similar to that 
obtained after DNAse 1 treatment, confirming that both DNA and fibronectin determined cell 
attachment to NETs. Since low or undetectable levels of α5β1 integrin prevents cell adhesion to 
NETs, this integrin is need to anchor cells in the web-like structure of NETs, allowing a close 
interaction between cells and DNA/histone complexes. 
This PhD thesis demonstrated that α5β1, αvβ3 and αIIbβ3 integrins modulate cell adhesion to NETs 
by binding to their common substrate fibronectin, found to be a protein component of NETs. In 
addition to mechanical trapping, integrin-mediated cell adhesion to NETs should be taken into 
account as a mechanism promoting cell-cell interactions at the interface with NETs. Therefore, by 
using integrins-specific antibodies or the RGD cyclic peptide is possible impairing the homing of 
different integrins-expressing cell types such as platelets, endothelial and cancer cells to specific 
sites of NETs accumulation, thus reducing NETs-dependent cancer-associated thrombosis and 
tumor progression. 
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INTRODUCTION 
Defensive properties and functions of neutrophils 
In humans, neutrophils or polymorphonuclear cells (PMNs) account for 50% to 70% of all 
circulating leukocytes and represent the first line of host defense against invading pathogens [1]. 
Mature neutrophils are released from the bone marrow in a highly regulated manner [2] and 
circulate in the blood as cells with a segmented nucleus and a cytoplasm enriched with granules and 
secretory vesicles. In response to infection, circulating neutrophils migrate towards invading 
pathogens in an ordered multistep process referred to as neutrophil recruitment. The initial steps of 
this process are the attachment of free-flowing neutrophils to the surface of the endothelium 
(capture) and their rolling along the vessel in the direction of blood flow [3]. These events are 
mainly mediated by the low-affinity dynamic interactions of selectins receptors on endothelial cells 
with their ligands on neutrophil surface. The subsequent step is the adhesion of rolling neutrophils 
to the endothelium. Chemokines immobilized on the luminal side of endothelium activate 
neutrophils thus inducing conformational changes of neutrophil surface integrins allowing them to 
interact with ligands expressed on the inflamed endothelium. The binding of integrins with their 
extracellular ligands activates signaling pathways inside the neutrophil thus stabilizing adhesion and 
initiating cell motility. While remaining firmly attached to the endothelium, neutrophils start to 
crawl searching for the preferential site of transmigration. Crawling neutrophils actively move 
towards endothelial junctions and this process mainly depends on the β2 integrin macrophage 1 
antigen (MAC-1) [4, 5]. Once neutrophils reach their extravasation site by intraluminal crawling, 
they have to cross the endothelial cell layer, the basement membrane and pericytes to enter the 
interstitial tissue. Endothelial transmigration requires integrins and multiple adhesion molecules and 
may occur via a paracellular (between endothelial cells) or transcellular (through an endothelial 
cell) route. The paracellular transmigration is usually preferred by neutrophils that reach the 
basement membrane in a few minutes. Although neutrophils have specific proteases that may digest 
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ECM proteins, they cross the basement membrane mainly by migration through less dense regions 
with low levels of ECM proteins. Finally, neutrophils migrate through the pericyte network by 
crawling along the cells and searching for permissive gaps between adjacent cells that allow them to 
leave the vasculature [3, 6, 7]. 
Once in the interstitial tissue, neutrophils need to find the site of infection where they can eliminate 
the invading pathogens. This is accomplished by site-directed migration of neutrophils in response 
to a chemotactic gradient, a process termed chemotaxis. Previous studies showed that there is a 
hierarchy of chemotactic molecules in an infected tissue [8, 9]. The chemoattractant molecules 
derived from bacterial products such as formyl-Met-Leu-Phe (fMLP) (end-target chemoattractant) 
dominate over other chemotactic stimuli released at intermediary sites (intermediate 
chemoattractant). Among all these migratory stimuli, neutrophils preferentially respond to end-
target chemoattractants so that interfering signals from local environment do not deviate them from 
the final destination. 
At the infectious site, neutrophils kill pathogens by essentially three mechanisms: phagocytosis, 
degranulation and release of neutrophil extracellular traps (NETs). During phagocytosis, the 
pathogens are firstly recognized and opsonized by engagement of specific receptors/antigens and 
then enclosed in a defined vacuole. Uptake is followed by fusion of the phagocytic vacuole with 
preformed granules containing NADPH oxidase subunits and hydrolytic enzymes. Finally, 
pathogens are killed by reactive oxygen species (ROS) generated by the activation of NADPH 
oxidase and exposure to proteinases and anti-microbial peptides such as cathepsins, defensins, 
lactoferrin and lysozyme. Furthermore, fusion of granules with the plasma membrane allows the 
release of antibacterial proteins into the extracellular space where they can act against extracellular 
pathogens. A third mechanism of extracellular bacterial killing is the formation and release of 
neutrophil extracellular traps by activated neutrophils. This process has been recently identified [10] 
and rapidly became a hot topic in research areas exploring not only the defensive properties of 
neutrophils but also their role in different pathological conditions. 
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Neutrophil extracellular traps (NETs) 
NETs are web-like structures released from activated neutrophils exposed to different pathogens 
including bacteria, virus or fungi. They are composed of decondensed chromatin associated with 
histones and other granular proteins such as myeloperoxidase (MPO), neutrophil elastase (NE), 
several antimicrobial peptides and matrix metalloproteinases 8, 9 and 25 (MMP8, MMP9 and 
MMP25) [3, 10-12]. The main function of NETs is the entrapment of pathogens and inactivation of 
their virulent factors through enzymatic degradation [13-17].  
The release of NETs occurs through a multistep process termed NETosis. In the first phases of this 
process, specific morphological changes can be observed in neutrophils including chromatin 
decondensation and loss of the classical lobulated nuclear morphology, disruption of nuclear 
membrane and subsequent mixing of nuclear and cytoplasmic content followed by extrusion into 
extracellular environment through plasma membrane disintegration [12, 18]. The process is also 
characterized by several biochemical changes including activation of peptidylargininedeiminase 4 
(PAD4), an enzyme that induces citrullination of histones, along with increased activity of MPO 
and NE [13-15, 18, 19]. It has been proposed that chromatin decondensation is primarily driven by 
histone citrullination since inhibition or knock-down of PAD4 impairs the ability of neutrophils to 
release NETs [20, 21]. Upon activation, NE was reported to translocate from cytoplasmic granules 
to the nucleus where it contributes to histone cleavage [19]. MPO also contributes to the 
decondensation of nuclear DNA and disruption of nuclear membrane even though this process was 
not completely elucidated. Due to their critical role in NETosis, citrullinated histones, MPO and NE 
are considered the major biomarkers of NETs associated with extracellular double-stranded DNA. 
At the end of the process, the release of NETs and the disruption of plasma membrane usually leads 
to cell death and loss of viable cell function such as migration and phagocytosis. It has recently 
been reported that certain NETosis-inducing stimuli may trigger neutrophils to release NETs by 
blebbing of the nuclear envelope and vesicular exportation [18, 21, 22]. In this case, the preserved 
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integrity of plasma membrane allows the neutrophil to remain viable and to retain several functions 
such as migration. This type of NETs release is termed vital NETosis as opposed to suicidal 
NETosis. 
In addition to bacteria, virus and fungi, different chemical compounds such as calcium ionophore 
A23187, phorbol 12-myristate 13-acetate (PMA) and potassium ionophore nigericin can stimulate 
neutrophils to release NETs. Some authors reported that calcium ionophore A23187 was more 
efficient and rapid than PMA to induce NETs release [13, 23]. 
 
NETs in infection and inflammation 
A number of pathogens can stimulate neutrophils to release NETs. Several bacterial molecules 
including the cell surface components LPS, lipoteichoic acid and their breakdown products are 
potent inducers of NETs. Bacteria are suggested to be entrapped by NETs due to the electrostatic 
interaction between the positively charged bacterial surface and the negatively charged chromatin 
fibers [24]. After entrapping, NETs are reported to disarm and inactivate bacteria mainly through 
the enzymatic activity of neutrophil elastase and the antimicrobial activity of histone and histone-
derived peptides [25]. Both Gram-positive and Gram-negative bacteria including Staphylococcus 
aureus, Salmonella typhimurium and Shigella flexneri can be entrapped by NETs. Similarly, 
Escherichia coli and Pseudomonas aeruginosa can be immobilized and eliminated by NETs [26]. 
The microbicidal activity of NETs against different pathogens results from the combined action of 
several components showing an enhanced effects due to their high local concentration on the NETs’ 
surface. For instance, NETs are reported to contain calprotectin, a cytosolic protein capable of 
disarming and killing Candida albicans [12]. The antifungal activity of NETs has been also 
assigned to calgranulin which chelates zinc, a cation required for fungal growth [24] and NETs 
toxicity for Aspergillus fumigatus and Cryptococcus neoformans was ascribed to this mechanism 
[26, 27]. Among other pathogens, NETs are able to eradicate several viruses mainly through the 
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MPO and defensins activity. MPO has a direct anti-viral effect against HIV-1 and cytomegalovirus 
while defensins have multiple modes of action especially against respiratory viruses like influenza 
A and RSV [26-28].  
The release of NETs by activated neutrophils may also have detrimental effects on the host. A panel 
of self molecules are exposed extracellularly on the surface of NETs and this may trigger a harmful 
inflammatory autoimmune response [29, 30]. NETs were detected in renal and skin biopsies of 
patients with systemic lupus erythematosus, an autoimmune disease characterized by the formation 
of auto-antibodies against chromatin and neutrophil components [31]. It was proposed that a high 
levels of cytokines such as TNF-α and IFN-α sensitize neutrophils to release NETs in response to 
anti-proteinase 3, anti-ribonucleoprotein, anti-defensin, or anti-LL-37 autoantibodies [32-34]. 
Furthermore, NETs are reported to be involved in the pathogenesis of other autoimmune diseases 
including rheumatoid arthritis [35], psoriasis [36, 37] and some types of vasculitis [7]. 
 
NETs in thrombosis 
Extensive evidences indicate that NETs have a relevant role in coagulation and thrombus formation 
since NETs can provide a scaffold for platelet and red blood cell adhesion and aggregation thus 
enhancing coagulation [38-40]. Biomarkers of NETs have been found in thrombi and plasma of 
both animal models and patients with deep venous thrombosis [38, 41]. Previous studies reported 
that NETs might promote thrombosis in different ways [15]. Several plasma proteins important for 
platelet adhesion and thrombus propagation such as fibronectin and von Willebrand factor may bind 
to NETs [40]. The major constituents of NETs, DNA, histones and proteases, all have procoagulant 
properties. Nucleic acids activate coagulation with RNA binding to both factor XII and XI in the 
intrinsic pathway [42, 43]. Histones increase thrombin generation in a platelet-dependent manner 
[44, 45]. Histones activate platelets and platelet activation, in turn, promotes coagulation. In 
addition, histones are cytotoxic to the endothelium and can induce macro and microthrombosis in 
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vivo. Serine proteases, such as neutrophil elastase, was shown to inactivate tissue factor pathway 
inhibitor (TFPI) through cleavage thus resulting in an increased procoagulant activity with 
consequent platelet activation and enhanced NETs formation. Massberg et al showed that thrombus 
formation in response to arterial vessel injury was reduced in mice deficient in neutrophil elastase 
and cathepsin G as compared to wild type animals [46]. In animal models of deep venous 
thrombosis, treatment with DNAse 1 that degrades NETs resulted in a significantly lower frequency 
of thrombus formation [38, 47]. In PAD4-deficient mice, the impaired production of NETs resulted 
in a strongly reduced formation of thrombi following inferior vena cava stenosis [48]. Interestingly, 
the PAD4-deficient mice retain normal tail bleeding time suggesting that NETs do not affect 
platelet plug formation in response to a small injury but they may have a critical role in the 
stabilization of thrombi in large vessels. This implies that targeting PAD4 for prevention of 
thrombosis would not likely cause spontaneous hemorrhages. 
The association between cancer and thrombosis is well established. An approximately 4-fold 
increased risk of venous thromboembolism has been reported for cancer patients as compared to 
general population [49]. Pancreatic and brain cancer patients have a higher risk of venous 
thromboembolism than breast and prostate cancer patients. Moreover, patients with metastatic 
disease have a higher risk than those with localized tumors [49]. Many factors including tissue 
factor, microparticles, cytokines, soluble P-selectin, elevation in coagulation factors, secretion of 
mucins, thrombocytosis and leukocytosis were involved in the prothrombotic state associated with 
cancer. Recently Demers et al investigated the role of NETs in lung thrombosis in two mouse tumor 
models [50]. An increased number of peripheral blood neutrophils was found in tumor-bearing 
animals and these neutrophils were more prone to release NETs as compared to those derived from 
healthy animals. The same authors reported that tumor-derived granulocyte colony-stimulating 
factor (G-CSF) was responsible for the neutrophilia and NETs release. Finally, hypercitrullinated 
histone H3, the main biomarker of NETs, was detected in thrombi in the lungs of these tumor-
bearing mice.  
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NETs and cancer 
Patients with various tumor types, including breast, lung and colorectal cancer often exhibit an 
increased number of neutrophils in peripheral blood [1]. In addition, the relative frequency of 
immature neutrophils is increased in certain types of cancer and this may be due to a tumor-induced 
emergency granulopoiesis in response to upregulation of several cytokines and chemokines. It is 
well established that neutrophils are recruited to tumor sites where they constitute a significant 
portion of inflammatory cell infiltrate and they may have both pro and anti-tumoral properties [51]. 
Neutrophils may exert pro-tumoral activity by different mechanisms, including the development of 
chronic inflammation, an enhanced tumor angiogenesis and modulation of cell migration and 
invasion. A high levels of tumor-infiltrating neutrophils are associated with advanced disease and 
poor clinical outcome in cancer patients [52-54]. Previous studies also showed antitumor activity of 
neutrophils. A number of antimicrobial mediators expressed by neutrophils such as defensins, 
proteases, myeloperoxidase, and reactive oxygen species may have potent tumor-cytotoxic activity. 
Furthermore, neutrophils also express cytokines, chemokines, and growth factors with the potential 
to recruit and activate cells of the innate and adaptive immune system [55-57]. Neutrophils may 
also release NETs at tumor site and the mechanisms by which they are formed and influence tumor 
microenvironment are not known. 
Previous studies reported the presence of NETs in Lewis lung carcinomas at sites of neutrophil 
accumulation especially in areas of apparent necrosis [58]. A similar pattern was observed in 
histological sections of human Ewing sarcoma [59]. 
The involvement of NETs in promoting metastasis has been recently investigated. In a model of 
systemic infection, Cools-Lartigue et al demonstrated microvascular depositions of NETs and 
consequent trapping of circulating lung carcinoma cells within DNA webs. NETs trapping was 
associated with increased formation of hepatic micrometastases at 48 hours and gross metastatic 
lesions at 2 weeks following tumor cell injection. These effects were abrogated by NETs inhibition 
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with DNAse 1 or neutrophil elastase inhibitor [60]. In an experimental mouse model, breast cancer 
cells induced neutrophils to release NETs in the absence of infection. NETs were detected by 
intravital microscopy around metastatic cancer cells in lung tissue and mice treated with DNAse 1-
coated nanoparticles showed reduced experimental metastases [61]. In a mouse model of sepsis, a 
condition promoting NETs deposition in liver sinusoid and lung capillaries, the intrasplenical 
injection of A549 cancer cells expressing β1-integrin resulted in their adhesion to hepatic sinusoids 
as assessed by intravital microscopy. Silencing of β1-integrin with targeted siRNA in cancer cells 
before injection caused a decrease of cell adhesion to NETs in liver sinusoids [62]. 
 
Integrins 
Integrins are transmembrane heterodimeric receptors composed of non-covalently associated α and 
β subunits, which integrate the extracellular matrix with the intracellular cytoskeleton to mediate 
cell migration and adhesion. A property of most integrins is their ability to bind a large spectrum of 
ligands. Furthermore, many extracellular matrix and cell surface adhesion proteins may bind to 
multiple integrin receptors. Several members of integrin superfamily bind to their extracellular 
ligands through the recognition of the tripeptide Arg-Gly-Asp (RGD). This motif was originally 
identified in fibronectin and subsequently it was found in many other protein components of the 
extracellular matrix (ECM) including vitronectin, von Willebrand factor, osteopontin, fibrinogen 
and laminin. The RGD motif can be recognized by different integrins including α5β1, αvβ3, αvβ5 
and αIIbβ3 [63-65]. 
Integrins are expressed on the plasma membrane in an inactive status in which they do not bind 
their ligands and do not transduce signals unless exposed to activating stimuli. Activation occurs 
through an “outside-in” and “inside-out” signaling that result in conformational changes that in turn 
increase the ligand-binding affinity. Integrin ligation by its own natural ligands triggers a signaling 
cascade in the “outside-in” direction by oligomerization and co-clustering with kinases and adaptor 
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proteins such as focal adhesion kinase and Src and by activating a number of intracellular 
mediators. The “inside-out” signaling occurs when intracellular signals induce dissociation of the α 
and β transmembrane domains and cytoplasmic tails followed by conformational changes and 
generation of a high affinity binding integrin [66]. 
Among members of the integrin family, a prominent role in angiogenesis and metastatic 
dissemination is played by αvβ3, αvβ5 and α5β1. Overexpression of these integrins is associated 
with poor prognosis and unfavorable outcomes [66-68]. Integrin αvβ3 is strongly upregulated at 
transcriptional level by pro-angiogenic growth factors or chemokines in activated endothelial cells. 
Expression and activation of this integrin was also found to be correlated with tumor invasion and 
metastases in melanomas, gliomas, ovarian and breast cancer. In particular, activated αvβ3 is 
reported to cooperate with metalloproteinase and to strongly promote metastasis in human breast 
cancer cells [69, 70]. Although less extensively studied, also αvβ5 is reported to be involved in 
tumor invasion and metastases in a variety of malignant tumors mainly of epithelial origin. In this 
respect, αvβ5 physically interacts with urokinase plasminogen activator receptor (uPAR) promoting 
proteolytic disruption of ECM, dysregulation of cell adhesion properties and urokinase-dependent 
cell migration in breast cancer [71]. 
Expression of α5β1 is strongly induced upon hypoxia and promotes tumor metastasis in breast 
cancer. Breast cancer cells with high α5β1 levels revealed a 3-fold increased cell invasiveness, 
compared with cells exhibiting low α5β1 expression [72]. Furthermore high α5β1 expression in 
clinical biopsies is associated with an increased risk of mortality. Previous studies reported that 
α5β1 integrin mediates neovascularization and aggressiveness through an increase of MMP-9 
activity in solid tumors like glioblastoma, melanoma and ovarian cancer [73, 74]. Mice injected 
with α5-silenced Lewis lung cancer cells showed lower burden of implanted tumors, and a dramatic 
decrease in lung metastases resulting in higher survival as compared with mice injected with wild-
type cells [75]. Integrins αvβ3 and α5β1 are reported to cooperate in different biological processes 
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such as regulation of cell contractility and movement, angiogenesis and maintenance of cancer 
stemness [72]. 
The integrin αIIbβ3 is the most abundant platelet surface receptor and is essential for adhesion, 
aggregation, and clot retraction. The principal ligand for αIIbβ3 is fibrinogen; however, fibronectin, 
vitronectin and von Willebrand factor (vWF) have also been demonstrated to have the ability to 
bind the integrin [76]. When fibrinogen or von Willebrand factor are bound to αIIbβ3, they can 
mediate cross bridging with other αIIbβ3 receptors on adjacent platelets [77].  Ligand binding to 
αIIbβ3 not only enables platelet–platelet interaction but also transmits an array of signals from the 
occupied and clustered receptor into the platelet mainly through members of Src family kinases [78-
80]. Furthermore, platelet αIIbβ3 has been involved in tumor cell-induced platelet aggregation and 
blockade of this integrin in models of pulmonary metastases reduced the metastatic dissemination 
of intravenously injected cancer cells [81]. 
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AIM OF THE STUDY 
Although a growing body of evidences indicates that NETs are involved in cancer-associated 
thrombosis and metastatic dissemination, the underlying mechanisms by which NETs mediate such 
processes and in particular cell adhesion and entrapment of circulating cancer cells have not been 
elucidated yet. Since integrins are the main mediators of cell adhesion, migration and invasion, we 
hypothesized that members of integrin family may have a role in promoting cell attachment to 
NETs. The aim of the present study was to test whether RGD-recognizing integrins such as α5β1, 
αvβ3 and αIIbβ3 may mediate cell adhesion to NETs thus investigating the interplay between 
cancer cells and neutrophils that may simultaneously promote a procoagulant state and metastatic 
dissemination. 
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MATERIALS AND METHODS 
Differentiation of HL-60 cells and NETs production 
Human HL-60 cell line was maintained in Roswell Park Memorial Institute (RPMI) 1640 
supplemented with 10% FBS. These cells have been widely used to study several leukocyte 
function including oxidative burst, adhesion, chemotaxis and migration [82]. We selected this cell 
line because upon differentiation it represents an abundant and daily available source of NETs that 
allowed us to perform adhesion assays avoiding cell-cell interaction and contamination with 
integrin substrates present in blood samples. 
Human HL-60 cells were differentiate into neutrophil-like cells using a standard protocol with 
slight modifications [83, 84]. Briefly, 1x106 HL-60 cells were grown in medium with 1.3% DMSO 
using T25 flasks in a humidified incubator at 5% CO2 and 37°C for 5 days adding fresh medium 
with 1.3% DMSO to the flasks at the third day. Then 1.5 x106 treated cells were plated into Petri 
dishes containing 10 ml of fresh medium with 1.3% DMSO to complete differentiation and allow 
cell attachment for additional 2 days. 
To confirm differentiation, changes in cell morphology were assessed by staining with May-
Grunwald-Giemsa and the expression of CD11b [85], CD16b [86] and CD177 [87] antigens, 
markers of neutrophil differentiation, was evaluated by flow cytometry. 
To induce the release of NETs, neutrophil-like cells were treated with 2.5 and 25 µM calcium 
ionophore (A23187, Sigma-Aldrich) or vehicle. Briefly, differentiated cells were plated onto Petri 
dishes in RPMI 1640 with or without 10% FBS at a density of 1x106 cells/ml and exposed to 
calcium ionophore for 4 h in a humidified incubator. After treatment, the conditioned medium was 
recovered and centrifuged at 310xg for 10 min at 4°C to obtain a cell-free NETs-enriched 
supernatant. This supernatant was then centrifuged at 18000xg for 10 min at 4°C and the pellet 
containing NETs was resuspended in 100 µl of cold PBS. Finally, double-stranded DNA 
concentration was determined using a NanoDrop ND-1000 spectrophotometer with V3.5.2 software 
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(NanoDrop Technology, Cambridge, UK) and cell-free isolated NETs were used as a stock for 
further experiments. Different stock suspensions were prepared and used to obtain experimental 
replicates. 
 
Cell lines for adhesion assays 
Human chronic myeloid leukemia K562 cells endogenously expressing α5β1 integrin (K562) and 
its derived clone, stably cotransfected with cDNA of αv and β3 subunits [88], overexpressing αvβ3 
integrin (K562αvβ3), were a generous gift of Dr. S.D. Blystone. Cells were grown in Iscove's 
modified Dulbecco's medium (IMDM) (Gibco Life Technologies) containing 10% FBS [89]. 
Human fibrosarcoma (HT-1080), glioblastoma (U-87 MG), prostate cancer (DU 145 and PC-3) and 
epidermoid carcinoma (A-431) cells were grown in Dulbecco's Modified  Eagle Medium (DMEM, 
Gibco Life Technologies) containing 10% FBS whereas non-small cell lung cancer (H1975) were 
cultured in complete RPMI 1640. All cells were maintained in a humidified incubator at 5% CO2 
and 37°C. Expression of α5β1, αvβ3, αvβ5 and αIIbβ3 integrins were tested by FACS analysis or 
western blotting of single chains. 
 
FACS analysis of integrin and antigen expression 
Levels of CD11b, CD16b and CD177 antigens as well as expression of α5β1 and αvβ3 integrins 
were determined by fluorescence-activated cell sorting (BD FACSAria II) [89]. Briefly, neutrophil-
like cells (5-10x105) were harvested and incubated with mouse monoclonal antibody anti-human 
CD11b conjugated with R-phycoerythrin (clone 2LPM19c, Dako), anti-human CD16b conjugated 
with APC (clone REA589, MiltenyiBiotec) or anti-human CD177 conjugated with FITC (clone 
REA258, MiltenyiBiotec) following manufacturers’ instructions for 1 h at 4°C in the dark. Then, 
cells were washed with PBS and analyzed by flow cytometry. Three independent experiments were 
performed for each antibody. Similarly, K562 and K562αvβ3 cells (5x105) were incubated with 1 
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mg/ml mouse monoclonal antibodies HA5 and LM609 (Chemicon) recognizing α5β1 and αvβ3 
integrins, respectively, for 1 h at 4°C in the dark. After washing with PBS, cells were incubated 
with FITC-conjugated anti-mouse IgG (Sigma-Aldrich), diluted 1:40, for 30 min at 4° C in the dark 
and then subjected to FACS using BD FACSDiva 8.0 software. Simultaneous representation of 
different histograms from the same cell line was obtained by Kaluza Flow Citometry analysis V1.2 
(Beckman Coulter). Two independent experiments were performed for each cell line and antibody. 
 
Western blot analysis of integrin expression 
Whole cell lysates were obtained using standard protocol. Briefly, cells were washed in PBS and  
then lysed on ice in 100 μl of RIPA lysis buffer (Tris-HCl pH 7.6, 150mM NaCl, 1% NP-40, 1% 
sodium deoxycholate, 0.1% SDS) with proteases and phosphatases inhibitors (Sigma-Aldrich). The 
suspension was then homogenized by passages through a 26-gauge needle and centrifuged at 
15700xg for 30 min at 4°C. Western blot analysis of proteins from whole cell lysates was carried 
out using a standard procedure. Briefly, protein samples (40 µg) were subjected to SDS-PAGE and 
then transferred to PVDF membranes. After blocking with 5% non-fat dry milk, membranes were 
probed by rabbit polyclonal antibodies (1:500) recognizing α5 (Chemicon), αIIb (Santa Cruz), β1 
(Chemicon), β3 (Santa Cruz) and β5 (Santa Cruz) chains whereas mouse monoclonal antibodies 
were used to probe αv chain (clone P2W7, 1:500, Santa Cruz) and actin (Sigma; 1 μg/mL). A 
commercially available ECL kit (GE Healthcare) was used to reveal the reaction. 
 
Qualitative and quantitative analysis of NETs 
Fluorescence microscopy was used to evaluate NETs formation. Briefly, 5x105 neutrophil-like cells 
were seeded in 24-well tissue culture plates with glass coverslips in serum-free HBSS with calcium 
and magnesium chloride at 37°C with 5% CO2 and allowed to attach. Then cells were treated with 
calcium ionophore and stained with Sytox Green cell-impermeable nucleic acid dye (5 µM, 
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Invitrogen). After washing with PBS, each coverslip was mounted on glass slide and examined by 
fluorescence microscopy. 
Quantitative analysis of NETs formation was performed with Sytox Green followed by plate reader 
assay. Briefly, 1x105 neutrophil-like cells were seeded in 96-well black plate in 100 µl of serum-
free HBSS with calcium and magnesium chloride and left for 1 h at 37°C, 5%CO2. After treatment 
with 2.5 and 25 µM A23187, Sytox Green was added at 5 µM for 10 min in a humidified incubator. 
The fluorescence was then measured using a PerkinElmer Multimode Plate Reader with EnSpire 
Manager Software and the results were expressed as percentage of total DNA release considering 
fluorescence readout obtained from cells lysed with 2% (vol/vol) Triton X-100 as 100% DNA 
release. Three independent experiments in triplicates were performed. 
 
Analysis of NETs protein components 
Samples from conditioned media of A23187-treated neutrophil-like cells or cell-free isolated NETs 
were analyzed by western blotting or immunoprecipitation. Levels of citrullinated histone H3 (Cit 
H3) were assayed after DNAse 1 treatment (40 UI/ml, Roche) for 15 min at room temperature 
followed by centrifugation at 400xg for 5 min at 4°C. Protein samples (50 µg, if not differently 
indicated) were subjected to western blot analysis as described above. Primary antibodies were anti-
citrullinated histone H3 (citrulline R2+R8+R17, Abcam), total anti-histone H3 (Abcam) and anti-
MPO (clone 2C7, Abcam), anti-fibronectin (clone 10/fibronectin, BD Biosciences) and anti-
vitronectin (clone VIT-2, Sigma) mouse monoclonal antibodies. Gels were stained with coomassie 
dye R-250 using ImperialTMprotein stain (Thermo Fisher Scientific) to obtain SDS-PAGE patterns 
of protein content and ensure equal loading. 
Proteins (1.5 mg) from conditioned media of unstimulated and A23187-stimulated neutrophil-like 
cells in RPMI 1640 with 10% FBS were incubated with 2.5 µg/ml of anti-fibronectin mouse 
monoclonal antibody overnight at 4°C under gentle rotation. The immunoprecipitated proteins 
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recovered by EZview Red Protein A Affinity Gel (Sigma-Aldrich) beads were separated by SDS-
PAGE and analyzed by immunoblotting using the indicated antibodies. 
 
Co-immunolocalization studies by confocal microscopy 
Co-immunolocalization studies were performed in the laboratory of Dr. Carriero at the National 
Cancer Institute of Naples using a 510 META LSM confocal microscopy (Carl Zeiss). Briefly, 
neutrophil-like cells (2x105) were seeded in serum-free HBSS and allowed to attach onto glass 
coverslip in 24-well flat-bottom plates for 1 h at 37°C. Then cells were treated with calcium 
ionophore A23187 (25 µM) to induce NETs release. Cells were fixed in formalin (2.5%) for 10 min 
at 4°C and incubated with rabbit polyclonal anti-citrullinated histone H3 (10 µg/ml) (Abcam) and 
mouse monoclonal anti-fibronectin (2.5 µg/ml) (clone 10/fibronectin, BD Biosciences) antibodies 
alone or in combination for 1 h at room temperature in the dark. Parallel experiments were 
performed by incubating permeabilized cells (0.1% Triton X-100) with mouse monoclonal antibody 
recognizing myeloperoxidase (MPO) (10 µg/ml, clone 2C7, Abcam). In an additional set of 
experiments glass coverslips were incubated overnight at 4°C with 5 µg of cell-free isolated NETs 
and then subjected to co-immunolocalization study using anti-Cit H3, anti-MPO and anti-
fibronectin antibodies as described. After washing with PBS containing 1% BSA, 1:700 goat Alexa 
Fluor 594 anti-rabbit IgG and 1:500 rabbit Alexa Fluor 488 anti-mouse IgG (Molecular Probes) 
were added for 45 min at room temperature in the dark. Then glass coverslips were washed twice 
with PBS, mounted with ProLong Gold Antifade Reagent (Invitrogen) and examined by confocal 
microscopy. 
 
Cell adhesion assays to NETs 
A panel of human cancer cell lines differentially expressing α5β1, αvβ3, αIIbβ3 and αvβ5 integrins, 
that is fibrosarcoma (HT-1080), glioblastoma (U-87 MG), non-small cell lung cancer (H1975), 
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prostate cancer (DU 145 and PC-3) and epidermoid carcinoma (A-431), was subjected to adhesion 
assays using NETs as adhesion substrate. Briefly, 24-well flat-bottom plates were incubated 
overnight at 4°C with 5 µg of NETs stock in 200 µl of PBS and with diluent or conditioned medium 
from unstimulated neutrophil-like cells as negative controls. After gentle washing with PBS and 
incubation with serum-free culture medium with 1% BSA for 1 h at room temperature, cells (3x105 
cells/well) were added and allowed to adhere for 1h at 37°C. Nonadherent cells were then removed 
by washing each well with serum-free culture medium whereas adherent cells were trypsinized and 
counted. Data are expressed as percentage of adherent cells compared to the total number of added 
cells. As negative controls, cells were seeded onto NETs coated wells that had been pre-treated with 
DNAse 1 (10000 UI/ml, Roche) for 15 min at room temperature. To test whether DNA digestion 
was optimal, samples of NETs suspension were incubated with DNAse 1 (10000 UI/ml) for 15 min 
and 30 min at RT and then loaded on 1.5 % agarose gel (w/v) containing 1 µg/ml ethidium bromide. 
To evaluate the role of α5β1 and αvβ3 integrins in promoting cell adhesion to NETs, cells were pre-
treated with 45 µg/ml for 1 h at 4 °C with anti-α5β1 P1D6 (Abcam) or anti-αvβ3 LM609 
(Chemicon) mouse monoclonal blocking antibodies and then seeded onto NETs coated plates at the 
final antibody concentration of 15 µg/ml. In addition to screen the adhesion ability of different 
integrins to NETs, a panel of cells were pre-incubated with a cyclic RGD peptide (10 μM) for 1 h at 
4°C and then added to NETs coated plates with a final peptide concentration of 3.3 μM. To test the 
adhesion properties of protein components of NETs, Proteinase K (1.8 mg/ml, Invitrogen) was 
added to pre-coated wells for 30 min at 37°C and then removed. 
Each cell line was subjected to three independent adhesion assays, including all experimental 
conditions, using different NETs stocks. In K562 and K562αvβ3 cells, three additional adhesion 
assays were performed using NETs released from neutrophil-like cells stimulated in the absence of 
serum, i.e. in exogenous vitronectin and fibronectin-free conditions. 
 
 
21 
 
Statistical analysis 
Statistical analysis was performed using the software MedCalc for Windows, version 10.3.2.0, 
(MedCalc Software, Mariakerke, Belgium). Data are expressed as mean ± SD if not differently 
indicated. Unpaired Student’s t test was used to compare means. A p value < 0.05 was considered 
statistically significant. 
 
RESULTS 
Characterization of neutrophil-like cells and NETs production 
Human acute promyelocitic leukemia HL-60 cells were differentiated in neutrophil-like cells adding 
1.3% DMSO to the culture medium for seven days. Morphological changes and neutrophil markers 
expression induced by differentiation were tested by May-Grunwald-Giemsa staining and by 
fluorescence activated cell sorting analysis using antibodies recognizing CD11b, CD16b and 
CD177 antigens. The mean percentages of neutrophil-like cells positively stained for CD11b, 
CD16b and CD177 were 60% ± 16%, 84% ± 19% and 78% ± 16%, respectively. 
Neutrophil-like cells were then treated with calcium ionophore A23187 to induce NETs release. 
The process of NETs formation was qualitatively and quantitatively evaluated by using Sytox 
Green nucleic acid dye. Figures 1 A and B show representative images of unstimulated and 
stimulated neutrophil-like cells obtained by fluorescence microscopy: positively stained web-like 
chromatin structures were found in the extracellular space of A23187-treated neutrophil-like cells 
(figure 1B) whereas they were absent in untreated cells (figure 1A). Furthermore, NETs and 
stimulated cells were positively stained for citrullinated histone H3 (Cit H3), a recognized marker 
of NETs structure (figure 1C). 
Quantitative analysis of NETs formation was performed by Sytox green plate reader assay. Figure 
1D shows a dose-dependent response of NETs formation induced by increasing concentration of 
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calcium ionophore. Considering fluorescence readout obtained from lysed cells as 100%, the 
percentage of extracellular DNA released by untreated cells was 29% ± 11% whereas treatment of 
neutrophil-like cells with 2.5 µM and 25 µM of calcium ionophore caused 58% ± 14% and 100% ± 
1% DNA release, respectively. These experiments showed that neutrophil-like cells treated with 
25μM of A23187 are able to release the maximal amount of NETs. 
 
Expression and co-immunolocalization of NETs markers 
To confirm that released NETs contained Cit H3, western blot analysis was performed on samples 
of conditioned media from neutrophil-like cells treated or not with increasing concentrations of 
calcium ionophore A23187 and on samples from NETs stock. Figure 2A shows undetectable levels 
of Cit H3 in the conditioned medium of untreated cells whereas a dose-dependent increase of this 
marker was observed in response to A23187. As expected, even higher levels of Cit H3 were found 
in samples of cell-free isolated NETs obtained by centrifugation of conditioned media from 
stimulated cells whereas the protein was faintly detected in the corresponding samples from 
unstimulated cells (figure 2B). Similarly, high levels of myeloperoxidase (MPO) were found in the 
same samples (figure 2A) and to confirm co-immunolocalization of the two markers, simultaneous 
staining of Cit H3 (red) and MPO (green) was performed and analyzed by confocal microscopy 
both in the presence of neutrophil-like cells (figure 3, upper panels) and in cell-free suspension of 
NETs (figure 3, lower panels). Fusion images (yellow, upper and lower panels) showed that Cit H3 
and MPO co-localize within NETs structure. 
 
Adhesion of α5β1 and αvβ3-expressing cells to NETs 
To test whether expression of integrins α5β1 and αvβ3 may modulate cell adhesion to NETs, K562 
and K562αvβ3 cells differentially expressing the two integrins were selected for cell adhesion 
assays to NETs. We preliminarily tested the expression of the two integrins in each cell line by 
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western blot analysis. Figure 4 shows that α5 and β1 chains are equally expressed in both cell lines 
whereas αv and β3 chains were expressed at high level only in K562αvβ3 cells stably cotransfected 
with cDNA of both chains. Levels of whole integrins were also tested by flow cytometry and the 
results are shown in figure 5. As expected, K562 cells endogenously expressed α5β1 integrin 
whereas levels of αvβ3 were undetectable in this cell line showing a fluorescence intensity similar 
to that of negative control (figure 5A). Conversely, K562αvβ3 cells expressed higher levels of αvβ3 
integrin as compared to α5β1 antigen (figure 5B). Although the single chains α5 and β1 were 
equally expressed in K562 and K562αvβ3 cells, the whole α5β1 integrin was detected in 75% ± 
19% of K562 cells and in 10% ± 10% of K562αvβ3 cells by FACS analysis using an antibody 
recognizing the whole integrin. This apparent discrepancy may be explained by the impaired 
assembly of α5β1 integrin on the plasma membrane of K562αvβ3 due to the predominant 
expression of αv and β3 chains in this cell line. The whole αvβ3 integrin was indeed expressed in 
94% ± 1% of K562αvβ3. Cell adhesion assays on NETs coated plates were then performed in the 
presence or absence of DNAse 1, blocking antibodies against α5β1 or αvβ3, alone or in 
combination with DNAse 1, and Proteinase K. The optimal degradation of double-stranded DNA in 
samples of NETs exposed to DNAse 1 treatment was confirmed by agarose gel electrophoresis 
(figure 6). DNA fragments of approximately 50-100 base pairs were found in DNAse 1 treated 
samples whereas double-stranded DNA remained indigested at the loading site in untreated 
samples. Furthermore, quantitative analysis of the agarose gel by ImageJ software (NIH, Bethesda, 
MD, USA) showed that the percentage of sample degradation at 15 min and 30 min was 95% and 
93%, respectively, as compared to the untreated sample. 
Figure 7A shows that when K562 cells were added to NETs coated plates, the mean percentage of 
adherent cells (expressed as percentage of adherent cells over the total number of seeded cells) was 
59% ± 8%. A statistically significant decrease of the percentage of adherent cells was observed after 
the addition of DNAse 1 (28% ± 1%, p<0.0001) or anti-α5β1 antibody (24% ± 3%, p<0.001) 
indicating that both nucleic acid and an integrin substrate were critical for cell adhesion to NETs. 
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Interestingly the combination of DNAse 1 and anti-α5β1 antibody almost completely blocked cell 
adhesion showing a mean percentage of adherent cells of 13% ± 1% (p=0.0001). This value was 
significantly lower than that obtained with each agent alone (vs DNAse, p<0.0001; vs anti-α5β1, 
p=0.0045). Negative controls performed with PBS or conditioned medium of unstimulated 
neutrophil-like cells showed a mean cell adhesion of 7% ± 3% and 5% ± 1%, respectively. 
Similarly, cell adhesion assays of K562αvβ3 cells to NETs coated plates showed 80% ± 3% of 
adherent cells that significantly decreased to 17% ± 3% in the presence of DNAse 1 (p<0.0001) and 
to 17% ± 4% when anti-αvβ3 blocking antibody was added (p<0.0001, figure 7B). The combination 
of DNAse 1 and anti-αvβ3 antibody resulted in 11% ± 4% of adherent cells, a value lower than that 
observed with DNAse 1 (p<0.05) and anti-αvβ3antibody (p=0.1017) alone. Negative controls 
performed with PBS and conditioned medium of unstimulated neutrophil-like cells showed a mean 
cell adhesion of 4 % ± 2% and 9% ± 1%, respectively. In both K562 and K562αvβ3 cells, the 
addition of Proteinase K caused inhibition of cell adhesion (p<0.05 for K562 and p<0.001 for 
K562αvβ3) confirming the crucial role of the protein content of NETs structure in cell adhesion 
(figure 7 A and B). Similar results were obtained using NETs released from neutrophil-like cells 
stimulated in serum-free conditions, i.e. in exogenous vitronectin and fibronectin-free conditions 
(Table 1). In particular, a significant reduction of cell adhesion was observed after treatment with 
DNAse 1 or anti-integrin antibody in both K562 (DNAse 1, p<0.01; anti-α5β1, p<0.01) and 
K562αvβ3 (DNAse 1, p<0.0001, anti-αvβ3, p<0.0001) cell lines. These experiments showed that 
both α5β1 and αvβ3 integrins are able to modulate adhesion of cancer cells to NETs. 
 
Fibronectin is a protein component of NETs 
Since both α5β1 and αvβ3 integrins bind with high affinity to fibronectin and vitronectin containing 
the RGD aminoacid sequence, we tested whether cell-free isolated NETs and conditioned media of 
stimulated and unstimulated neutrophil-like cells contained these integrin substrates. Western blot 
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analysis in figure 8A shows a dose-dependent increase of fibronectin levels in the conditioned 
medium of stimulated neutrophil-like cells whereas a faint fibronectin signal was observed in 
samples of conditioned medium from unstimulated cells using both standard and serum free 
conditions (i.e. in exogenous vitronectin and fibronectin-free conditions) (figure 8A, left and right 
panels, respectively). High levels of fibronectin were also found in samples of cell-free isolated 
NETs obtained by stimulating neutrophil-like cells in both standard and serum-free conditions 
(figure 8B, left and right panels, respectively) whereas the protein was undetectable in the 
corresponding negative control. Vitronectin levels were undetectable in all samples (figure 9). 
Immunoprecipitation of proteins from conditioned media of unstimulated and stimulated neutrophil-
like cells showed an undetectable, faint or strong signal for fibronectin in samples from untreated, 
2.5 μM and 25 μM of A23187 treated cells, respectively (figure 10). Furthermore, a strong signal 
for histone H3 was found only in conditioned medium of highly stimulated neutrophil- like cells 
indicating that fibronectin directly or indirectly interacts with histone H3 (figure 10). To test 
whether fibronectin is localized within NETs, co-immunolocalization studies of fibronectin and Cit 
H3 were performed using confocal microscopy in stimulated neutrophil-like cells and in NETs 
stock (figure 11). Representative images of NETs in the extracellular space of stimulated 
neutrophil-like cells (figure 11, upper and middle panels) positively stained with anti-fibronectin 
antibody (green) and with anti-Cit H3 antibody (red) and merged images showed a clear co-
localization of the two proteins in the structure of NETs. Similar results were obtained in cell-free 
isolated NETs (figure 11, lower panels). These findings taken together confirmed that fibronectin is 
localized within NETs and modulates cell adhesion to NETs through the engagement of α5β1 and 
αvβ3 integrins, providing mechanistic clues on the in vivo interaction of NETs with different types 
of cells expressing these integrins including peripheral blood or activated endothelial cells as well 
as cancer cells. 
 
 
26 
 
Integrin-dependent adhesion to NETs of different cancer cell lines 
To investigate the ability of different RGD-binding integrins to mediate adhesion to NETs, a panel 
of human cancer cell lines with a variable expression of α5β1, αvβ3, αIIbβ3 and αvβ5 integrins was 
subjected to adhesion assays to NETs in the presence and absence of an excess of cyclic RGD 
peptide and compared to DNAse 1 treated samples. The expression of each integrin chain was 
tested by western blotting in whole lysates of HT-1080, U-87 MG, DU 145, PC-3, H1975 and A-
431 cells. Figure 12 shows representative images of western blot analysis. Levels of α5 were 
undetectable in A-431 cells and faintly detected in PC-3 whereas all other cell lines expressed this 
integrin chain. High expression of αv was found in all cell lines except A-431 cells whereas levels 
of αIIb chain were higher in U-87 MG, HT-1080 and H1975 cells than in DU 145, PC-3 and A-431 
cells. Among all β chains analyzed, A-431 cells lacked β1 chain whereas PC-3 cells showed only a 
faint signal for the same protein. Finally, β5 expression was undetectable in U-87 MG cells whereas 
β3 was found in all cell lines. 
Table 2 reports the results of adhesion assays on NETs of each cell line in the presence or absence 
of DNAse 1 or excess of cyclic RGD peptide. The addition of cyclic RGD peptide reduced adhesion 
of HT-1080 and U-87 MG cells to values similar to those obtained with DNAse 1 treatment and 
unstimulated CM as negative control (figure 13). In H1975 cells, competition with cyclic RGD 
peptide caused a partial reduction of adhesion to NETs lower than that obtained with DNAse 1 
treatment (figure 13). It is worthy to note that HT-1080, U-87 MG and H1975 have a similar pattern 
of α5β1, αvβ3 and αIIbβ3 expression indicating that these three integrins may contribute to 
adhesion to NETs depending on their relative affinity for fibronectin. An equivalent statistically 
significant reduction of adhesion was obtained by both cyclic RGD peptide and DNAse 1 treatment 
in DU 145 cells that, however, remained higher than negative controls (figure 13). Finally PC-3 and 
A-431 cells showed the lowest NETs-dependent and integrin-dependent adhesion with values 
similar to negative controls in all conditions (figure 13). These data along with the results obtained 
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in K562 and K562αvβ3 cells, indicate that the integrins having a major role in the adhesion to NETs 
are α5β1 and αvβ3 since the low expression of α5β1 in PC-3 and A-431 prevents cell adhesion to 
NETs whereas high levels of αvβ3 enhance cell adhesion to NETs. 
 
DISCUSSION 
Our study in K562 and K562αvβ3 cells showed that α5β1 and αvβ3 integrins mediate cell adhesion 
to NETs by binding to their common substrate fibronectin, which was found to co-localize with Cit 
H3 inside the web-like structure of NETs and to interact directly or indirectly with histone H3. 
Treatment with DNAse 1 and blocking antibodies against α5β1 and αvβ3 integrins inhibited cell 
adhesion to NETs and when used in combination almost completely blocked cell adhesion 
indicating that both DNA and fibronectin were relevant in determining cell attachment to NETs. 
From quantitative data of cell adhesion, it is conceivable that treatment with DNAse 1 alone would 
digest DNA, disrupt the web-like structure of NETs and prevent the interaction of DNA/histone 
complexes with fibronectin thus inhibiting cell adhesion not only to DNA but also to fibronectin. 
Since treatment with blocking anti-integrin antibodies resulted in a reduction of cell adhesion 
similar to that obtained with DNAse 1, it is likely that cell adhesion to NETs may start with 
integrin-binding to fibronectin that would attract cells near to DNA/histone complexes allowing a 
stable cell interaction with DNA. 
NETs incubated with plasma were reported to bind to several plasma proteins including fibronectin, 
von Willebrand factor and fibrinogen [40]. In our experiments, fibronectin was originated from 
neutrophil-like cells, since its levels were faintly detected in the conditioned medium of 
unstimulated neutrophil-like cells and increased in a dose-dependent manner in response to 
A23187. It is unclear whether fibronectin enter the structure of NETs during their formation or 
simply binds to NETs in the extracellular space. In this respect, fibronectin was reported to have a 
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moderately high affinity for eukaryote double-stranded DNA and a DNA-binding domain was 
described in human plasma fibronectin [90]. 
Two distinct pathways of NETs formation have been reported in human neutrophils: the PMA-
induced NOX-dependent [14, 91] and the calcium ionophore-induced NOX-independent 
mechanisms [23]. The end point of both mechanisms is chromatin decondensation associated with 
histone citrullination followed by extrusion of nuclear DNA into the extracellular environment. The 
process is dependent on the generation of reactive oxygen species (ROS) and the migration of the 
protease neutrophil elastase (NE) and myeloperoxidase (MPO) from granules to the nucleus. The 
disruption of nuclear membrane that occurs during the process leads to the coalescence of 
nucleoplasm and cytoplasm so that cytoplasmic proteins including fibronectin can bind to 
DNA/histone complexes. 
Cellular fibronectin is synthesized by many cell types, including fibroblasts and endothelial cells. It 
is an old notion that neutrophils, in addition to carry receptors for fibronectin on their plasma 
membrane, are also able to synthesize and secrete fibronectin [92, 93] especially at inflammatory 
and tissue injury sites. Similarly, HL-60 cells are reported to secrete fibronectin and to acquire 
receptors for fibronectin during their differentiation along the granulocytic pathway [94]. The main 
implication of the presence of fibronectin in the web-like structure of NETs is that it provides 
specific binding sites for several integrins expressed on the plasma membrane of neutrophils, 
platelets, endothelial and cancer cells. 
When we screened a panel of cancer cell lines endogenously expressing a variety of integrins for 
their ability to bind to NETs, we found that the concomitant expression of α5β1, αvβ3 and αIIbβ3 
was associated to an enhanced adhesion to NETs and the addition of an excess of cyclic RGD 
peptide inhibited such adhesion although to a different extent in each cell line. The maximal 
reduction of integrin-dependent adhesion to NETs was similar to that obtained after DNAse 1 
treatment confirming that both DNA and fibronectin were relevant in determining cell attachment to 
NETs. The partial inhibition of adhesion by cyclic RGD peptide in certain cell lines may be due to 
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suboptimal competition for integrins with low affinity for fibronectin such as αvβ5 [95] or to the 
expression of other integrins not analyzed in the panel. The observation that low or undetectable 
levels of α5β1 integrin prevents cell adhesion to NETs suggests that this integrin is relevant to 
promote a stable cell interaction with DNA by binding to fibronectin. It is conceivable that α5β1 
integrin serves to anchor cells to the web-like structure allowing their close interaction with 
DNA/histone complexes. Similarly, α5β1 may cooperate with αvβ3 and other integrins favoring 
their binding to fibronectin. In agreement with our observations a recent study reported that 
silencing of β1-integrin with targeted siRNA in A549 lung cancer cells caused a decrease of cell 
adhesion to NETs in liver sinusoids as assessed by intravital microscopy in a mouse model of 
metastatic dissemination [62]. 
Our findings taken together indicate that, in addition to mechanical trapping and aspecific 
adsorption of different cell types driven by DNA/histone complexes, integrin-mediated cell 
adhesion to NETs should be taken into account as a mechanism promoting cell-cell interactions at 
the interface with NETs. By preventing fibronectin binding to integrins, specific inhibitors or 
antibodies may disrupt such cell-cell interactions and impair homing of circulating cancer cells to 
specific sites of NETs accumulation thus reducing NETs-dependent metastatic dissemination. 
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TABLES 
Table 1. Adhesion of K562 and K562αvβ3 cells to NETs isolated in serum-free conditions 
 K562 cells K562ανβ3 cells 
PBS 11% ± 7% 6% ± 1% 
Unstimulated CM 7% ± 4% 4% ± 2% 
NETs coated 62% ± 14% 61% ± 1% 
+ DNAse 1 10% ± 7% 10% ± 2% 
+ anti-integrin blocking Ab 10% ± 3% 8% ± 3% 
+ DNAse 1 + anti-integrin blocking Ab 6% ± 3% 5% ± 2% 
+ Proteinase K 21% ± 4% 19% ± 4% 
 
Adhesion of K562 and K562αvβ3 cells to NETs obtained from neutrophil-like cells stimulated with 25 µM A23187 in 
serum free conditions, i.e. in exogenous vitronectin and fibronectin-free conditions. Data are expressed as percentage of 
adherent cells compared to the total number of added cells and the mean ± SD of three independent experiments is 
reported for each condition. 
 
Table 2. Adhesion assay to NETs of HT-1080, U-87 MG, H1975, DU 145, PC-3 and A-431 cells 
 
 
 
 
PBS 
 
 
 
Unstimulated 
CM 
 
 
 
NETs coated 
 
 
 
NETs coated + 
DNAse 1 
 
 
 
NETs coated + 
cyclic RGD 
peptide 
HT-1080 38% ± 6% 47% ± 6% 101% ± 2% 49% ± 1% 59% ± 2% 
U-87 MG 31% ± 4% 42% ± 3% 99% ± 12% 64% ± 10% 65% ± 14% 
H1975 15% ± 8% 30% ± 9%     66% ± 8% 37% ± 8% 57% ± 8% 
DU 145 2% ± 1% 9% ± 3% 50% ± 4% 25% ± 5% 33% ± 3% 
PC-3 21% ± 3% 24% ± 3% 39% ± 8% 30% ± 3% 28% ± 2% 
A-431 65% ± 11% 61% ± 11% 57% ± 17% 56% ± 9% 46% ± 12% 
 
Adhesion assay of integrins-expressing HT-1080, U-87 MG, H1975, DU 145, PC-3 and A-431 human cancer cell lines 
using cell-free isolated NETs as substrate. The results represent the mean ± SE of three independent experiments and 
are expressed as percentage of adherent cells compared to the total number of plated cells. 
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FIGURES 
Figure 1. Qualitative and quantitative analysis of NETs formation induced by treatment of 
neutrophil-like cells with A23187 
 
Representative images obtained by fluorescence microscopy of neutrophil-like cells stained with Sytox Green cell-
impermeable nucleic acid dye in basal conditions (A) and after stimulation with 25 µM A23187 for 4 h. Scale bar, 20 
µm (B). Representative image obtained by fluorescence microscopy at higher magnification showing morphological 
details of NETs stained with antibody recognizing Cit H3. Scale bar, 5 µm (C). Results of three independent 
fluorescence plate reader assays in unstimulated and stimulated neutrophil-like cells expressed as percentage of total 
DNA released from lysed cells (D). 
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Figure 2. Levels of citrullinated histone H3, total histone H3 and myeloperoxidase in NETs 
 
Western blot analysis of citrullinated histone H3 (Cit H3), total histone H3 (Total H3) and myeloperoxidase (MPO) in 
samples of NETs-enriched conditioned media (A) and cell-free isolated NETs (B) compared to the corresponding 
negative control. 
 
 
Figure 3. Co-localization of citrullinated histone H3 and myeloperoxidase in NETs 
 
42 
 
 
Representative images obtained with confocal microscopy showing co-localization of MPO (green) and Cit H3 (red) in 
neutrophil-like cells stimulated in serum-free conditions with 25 µM A23187 for 4 h (upper panels) or in cell-free 
isolated NETs (lower panels). Merged images (yellow) showed the co-localization of MPO and Cit H3 confirming the 
typical features of NETs. 
 
 
Figure 4. Levels of α5, β1, αv and β3 single chain expression in K562 and K562αvβ3 cells by 
western blotting 
 
Samples of whole cell lysates (40 µg of proteins) from K562 and K562αvβ3 cells were subjected to western blot 
analysis using anti-α5 (Chemicon), anti-β1 (Chemicon), anti-β3 (Santa Cruz) rabbit polyclonal antibodies and anti-αv 
(clone P2W7, Santa Cruz) mouse monoclonal antibody. Actin ensured equal loading of samples. 
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Figure 5. Relative levels of α5β1 and αvβ3 integrins expression in K562 and K562αvβ3 cells by 
FACS 
 
Simultaneous representation of different histograms from the same cell line obtained by Kaluza Flow Cytometry 
analysis V1.2 (Beckman Coulter). Expression of α5β1 and αvβ3 integrins in human K562 cells (A) and its derived clone 
K562αvβ3 (B) were determined by flow cytometry analysis using primary monoclonal antibodies HA5 (blue 
histograms) and LM609 (green histograms) recognizing α5β1 and αvβ3 integrins, respectively, and compared to the 
corresponding negative control (red histograms). Two independent experiments were performed for each cell line and 
antibody. 
 
Figure 6. DNA degradation of NETs samples by DNAse 1 treatment 
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Samples of cell-free isolated NETs were incubated with DNAse 1 (10000 UI/ml) for 15 min and 30 min at room 
temperature and then loaded on 1.5 % agarose gels (w/v) prepared in Tris-borate-EDTA buffer containing 1 µg/ml 
ethidium bromide. NETs DNA samples (8 µg) treated with DNAse 1 for 15 min (lane 3) or 30 min (lane 4) showed the 
same smearing pattern along the gel whereas the untreated NETs sample (1 µg) did not show the presence of DNA 
fragments and remained undigested at the loading site (lane 2). Lane 1 and 5 show DNA molecular weight markers 
(ladder base pairs). 
 
Figure 7. Adhesion of K562 and K562αvβ3 cells to NETs 
 
 
 
Results of adhesion assay of K562 and K562αvβ3 are expressed as percentage of adherent cells compared to the total 
number of added cells and for each condition is reported the mean ± SD of three independent experiments performed 
using different NETs stocks obtained from the stimulation of newly differentiated HL-60 cells in the presence of 10% 
FBS. Statistical significant differences between NETs coated and each experimental condition are indicated by symbols 
*, ** and ***, meaning p<0.05, p< 0.01 and p<0.001, respectively. 
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Figure 8. Protein levels of fibronectin in NETs 
 
 
 
Levels of fibronectin were determined by Western blot analysis performed on samples of conditioned media of 
neutrophil-like cells stimulated or not with increasing concentration of A23187 in the presence (left panels, 50 µg of 
protein per lane) or absence (right panels, 5 µg of protein per lane ) of serum (A). Results of western blotting on 
samples of NETs preparations obtained by stimulating neutrophil-like cells with 25 µM A23187 for 4 h in the presence 
(left panels, 50 µg of protein per lane) or absence (right panels, 5 µg of protein per lane) of serum compared to the 
corresponding negative control from unstimulated cells (B). Gels were stained with Imperial protein stain to obtain 
SDS-PAGE patterns of protein content and ensure equal loading. 
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Figure 9. Western blot analysis of vitronectin expression in NETs 
 
 
 
Samples of conditioned medium from unstimulated and stimulated neutrophil-like cells (A) or from cell-free isolated 
NETs (B) were subjected to western blot analysis (50 µg of proteins) using an anti-vitronectin monoclonal antibody 
(clone VIT-2, Sigma) and purified vitronectin (Promega) as positive control. Vitronectin was undetectable in all 
samples except positive control. 
 
 
Figure 10. Interaction between fibronectin and histone H3 in NETs 
 
 
 
Immunoprecipitation of conditioned media from unstimulated and A23187-stimulated neutrophil-like cells was 
performed using anti-fibronectin antibody followed by SDS-PAGE of the immunoprecipitated proteins and 
immunoblotting with the indicated antibodies. 
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Figure 11. Co-localization of citrullinated histone H3 with fibronectin in NETs 
 
 
 
 
Representative images obtained with confocal microscopy showing co-localization of fibronectin (green) and Cit H3 
(red) in neutrophil-like cells stimulated in serum-free conditions with 25 µM of A23187 for 4 h (upper and middle 
panels) or in cell-free isolated NETs (lower panels). Merged images showed a clear co-localization of Cit H3 and 
fibronectin in the structure of NETs at early (upper panels) and late (middle panels) phases of the process coexisting in 
different fields as well as in NETs after their isolation procedures (lower panels). 
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Figure 12. Protein expressions of α5, αIIb, αv, β1, β3 and β5 chain integrin in U-87 MG, HT-
1080, DU 145, PC-3, H1975 and A-431 cells 
 
 
 
 
 
 
Western blotting of whole cell lysates from U-87 MG, HT-1080, DU 145, PC-3, H1975 and A-431 cells. Proteins (40 
µg) were separated by SDS-PAGE using 4-12% polyacrilamyide gels and PVDF membranes blotted with the indicated 
antibodies. Actin ensured equal loading. 
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Figure 13. Cell adhesion to NETs of integrins-expressing HT-1080, U-87 MG, H1975, DU 145, 
PC-3 and A-431 human cancer cell lines 
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Different cell-free isolated NETs were used to perform cell adhesion and obtain experimental replicates for each cell 
line tested. Results are expressed as percentage of adherent cells compared to the total number of added cells and the 
mean ± SE of three independent experiments is reported for each condition. Statistical significant differences between 
NETs coated and each experimental condition are indicated by symbols *, ** and ***, meaning p<0.05, p< 0.01 and 
p<0.001, respectively. 
